Review



anti hcd19 apc antibodies  (Miltenyi Biotec)


Bioz Verified Symbol Miltenyi Biotec is a verified supplier
Bioz Manufacturer Symbol Miltenyi Biotec manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 95
      Buy from Supplier

    Structured Review

    Miltenyi Biotec anti hcd19 apc antibodies
    Anti Hcd19 Apc Antibodies, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 127 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti hcd19 apc antibodies/product/Miltenyi Biotec
    Average 95 stars, based on 127 article reviews
    anti hcd19 apc antibodies - by Bioz Stars, 2026-02
    95/100 stars

    Images



    Similar Products

    anti hcd19 apc antibodies  (Miltenyi Biotec)
    95
    Miltenyi Biotec anti hcd19 apc antibodies
    Anti Hcd19 Apc Antibodies, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti hcd19 apc antibodies/product/Miltenyi Biotec
    Average 95 stars, based on 1 article reviews
    anti hcd19 apc antibodies - by Bioz Stars, 2026-02
    95/100 stars
    		  Buy from Supplier
    anti cd19 apc fire810  (Miltenyi Biotec)
    95
    Miltenyi Biotec anti cd19 apc fire810
    Anti Cd19 Apc Fire810, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti cd19 apc fire810/product/Miltenyi Biotec
    Average 95 stars, based on 1 article reviews
    anti cd19 apc fire810 - by Bioz Stars, 2026-02
    95/100 stars
    		  Buy from Supplier
    anti human cd19 apc h7  (Miltenyi Biotec)
    95
    Miltenyi Biotec anti human cd19 apc h7
    Anti Human Cd19 Apc H7, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti human cd19 apc h7/product/Miltenyi Biotec
    Average 95 stars, based on 1 article reviews
    anti human cd19 apc h7 - by Bioz Stars, 2026-02
    95/100 stars
    		  Buy from Supplier
    cd3 cd19 antigen pe a ntigen apc  (Miltenyi Biotec)
    94
    Miltenyi Biotec cd3 cd19 antigen pe a ntigen apc
    Cd3 Cd19 Antigen Pe A Ntigen Apc, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd3 cd19 antigen pe a ntigen apc/product/Miltenyi Biotec
    Average 94 stars, based on 1 article reviews
    cd3 cd19 antigen pe a ntigen apc - by Bioz Stars, 2026-02
    94/100 stars
    		  Buy from Supplier
    anti cd19 phycoerythrin mabs  (Miltenyi Biotec)
    97
    Miltenyi Biotec anti cd19 phycoerythrin mabs
    Belimumab treatment affects the B-cell subpopulations in patients with SLE. FACS analysis was performed on B cell subsets within the PBMCs isolated from patients with SLE before and 1, 3, 6, and 12 months after treatment with belimumab. ( A – C ) Frequencies of all cell subsets: ( A ) Total B cells (CD3 − <t>CD19</t> + ), ( B ) HVEM high naive B cells (CD19 + CD27 − HVEM high ), HVEM high memory B cells (CD19 + CD27 + HVEM high ), ( C ) BTLA high naive B cells (CD19 + CD27 − BTLA high ), BTLA high memory B cells (CD19 + CD27 + BTLA high ), and BTLA low naive B cells (CD19 + CD27 − BTLA low ). Each dot represents an individual patient sample ( n = 16), and bars represent the mean ± SD. Statistical analyses were performed using a mixed-effects model followed by Dunnett’s post hoc test to compare the data before and 1, 3, 6, and 12 months after treatment. Statistically significant changes are marked with asterisks (* p < 0.05, ** p < 0.01, and *** p < 0.001).
    Anti Cd19 Phycoerythrin Mabs, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti cd19 phycoerythrin mabs/product/Miltenyi Biotec
    Average 97 stars, based on 1 article reviews
    anti cd19 phycoerythrin mabs - by Bioz Stars, 2026-02
    97/100 stars
    		  Buy from Supplier
    anti human cd19 antibody conjugated with apc  (Miltenyi Biotec)
    96
    Miltenyi Biotec anti human cd19 antibody conjugated with apc
    Belimumab treatment affects the B-cell subpopulations in patients with SLE. FACS analysis was performed on B cell subsets within the PBMCs isolated from patients with SLE before and 1, 3, 6, and 12 months after treatment with belimumab. ( A – C ) Frequencies of all cell subsets: ( A ) Total B cells (CD3 − <t>CD19</t> + ), ( B ) HVEM high naive B cells (CD19 + CD27 − HVEM high ), HVEM high memory B cells (CD19 + CD27 + HVEM high ), ( C ) BTLA high naive B cells (CD19 + CD27 − BTLA high ), BTLA high memory B cells (CD19 + CD27 + BTLA high ), and BTLA low naive B cells (CD19 + CD27 − BTLA low ). Each dot represents an individual patient sample ( n = 16), and bars represent the mean ± SD. Statistical analyses were performed using a mixed-effects model followed by Dunnett’s post hoc test to compare the data before and 1, 3, 6, and 12 months after treatment. Statistically significant changes are marked with asterisks (* p < 0.05, ** p < 0.01, and *** p < 0.001).
    Anti Human Cd19 Antibody Conjugated With Apc, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti human cd19 antibody conjugated with apc/product/Miltenyi Biotec
    Average 96 stars, based on 1 article reviews
    anti human cd19 antibody conjugated with apc - by Bioz Stars, 2026-02
    96/100 stars
    		  Buy from Supplier
    cd19 car apc rea1297 miltenyi biotec  (Miltenyi Biotec)
    95
    Miltenyi Biotec cd19 car apc rea1297 miltenyi biotec
    Belimumab treatment affects the B-cell subpopulations in patients with SLE. FACS analysis was performed on B cell subsets within the PBMCs isolated from patients with SLE before and 1, 3, 6, and 12 months after treatment with belimumab. ( A – C ) Frequencies of all cell subsets: ( A ) Total B cells (CD3 − <t>CD19</t> + ), ( B ) HVEM high naive B cells (CD19 + CD27 − HVEM high ), HVEM high memory B cells (CD19 + CD27 + HVEM high ), ( C ) BTLA high naive B cells (CD19 + CD27 − BTLA high ), BTLA high memory B cells (CD19 + CD27 + BTLA high ), and BTLA low naive B cells (CD19 + CD27 − BTLA low ). Each dot represents an individual patient sample ( n = 16), and bars represent the mean ± SD. Statistical analyses were performed using a mixed-effects model followed by Dunnett’s post hoc test to compare the data before and 1, 3, 6, and 12 months after treatment. Statistically significant changes are marked with asterisks (* p < 0.05, ** p < 0.01, and *** p < 0.001).
    Cd19 Car Apc Rea1297 Miltenyi Biotec, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd19 car apc rea1297 miltenyi biotec/product/Miltenyi Biotec
    Average 95 stars, based on 1 article reviews
    cd19 car apc rea1297 miltenyi biotec - by Bioz Stars, 2026-02
    95/100 stars
    		  Buy from Supplier
    cd19  (Miltenyi Biotec)
    95
    Miltenyi Biotec cd19
    Belimumab treatment affects the B-cell subpopulations in patients with SLE. FACS analysis was performed on B cell subsets within the PBMCs isolated from patients with SLE before and 1, 3, 6, and 12 months after treatment with belimumab. ( A – C ) Frequencies of all cell subsets: ( A ) Total B cells (CD3 − <t>CD19</t> + ), ( B ) HVEM high naive B cells (CD19 + CD27 − HVEM high ), HVEM high memory B cells (CD19 + CD27 + HVEM high ), ( C ) BTLA high naive B cells (CD19 + CD27 − BTLA high ), BTLA high memory B cells (CD19 + CD27 + BTLA high ), and BTLA low naive B cells (CD19 + CD27 − BTLA low ). Each dot represents an individual patient sample ( n = 16), and bars represent the mean ± SD. Statistical analyses were performed using a mixed-effects model followed by Dunnett’s post hoc test to compare the data before and 1, 3, 6, and 12 months after treatment. Statistically significant changes are marked with asterisks (* p < 0.05, ** p < 0.01, and *** p < 0.001).
    Cd19, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd19/product/Miltenyi Biotec
    Average 95 stars, based on 1 article reviews
    cd19 - by Bioz Stars, 2026-02
    95/100 stars
    		  Buy from Supplier
    cd19 apc  (Miltenyi Biotec)
    95
    Miltenyi Biotec cd19 apc
    Belimumab treatment affects the B-cell subpopulations in patients with SLE. FACS analysis was performed on B cell subsets within the PBMCs isolated from patients with SLE before and 1, 3, 6, and 12 months after treatment with belimumab. ( A – C ) Frequencies of all cell subsets: ( A ) Total B cells (CD3 − <t>CD19</t> + ), ( B ) HVEM high naive B cells (CD19 + CD27 − HVEM high ), HVEM high memory B cells (CD19 + CD27 + HVEM high ), ( C ) BTLA high naive B cells (CD19 + CD27 − BTLA high ), BTLA high memory B cells (CD19 + CD27 + BTLA high ), and BTLA low naive B cells (CD19 + CD27 − BTLA low ). Each dot represents an individual patient sample ( n = 16), and bars represent the mean ± SD. Statistical analyses were performed using a mixed-effects model followed by Dunnett’s post hoc test to compare the data before and 1, 3, 6, and 12 months after treatment. Statistically significant changes are marked with asterisks (* p < 0.05, ** p < 0.01, and *** p < 0.001).
    Cd19 Apc, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd19 apc/product/Miltenyi Biotec
    Average 95 stars, based on 1 article reviews
    cd19 apc - by Bioz Stars, 2026-02
    95/100 stars
    		  Buy from Supplier
    anti cd19 apc vio770  (Miltenyi Biotec)
    95
    Miltenyi Biotec anti cd19 apc vio770
    Belimumab treatment affects the B-cell subpopulations in patients with SLE. FACS analysis was performed on B cell subsets within the PBMCs isolated from patients with SLE before and 1, 3, 6, and 12 months after treatment with belimumab. ( A – C ) Frequencies of all cell subsets: ( A ) Total B cells (CD3 − <t>CD19</t> + ), ( B ) HVEM high naive B cells (CD19 + CD27 − HVEM high ), HVEM high memory B cells (CD19 + CD27 + HVEM high ), ( C ) BTLA high naive B cells (CD19 + CD27 − BTLA high ), BTLA high memory B cells (CD19 + CD27 + BTLA high ), and BTLA low naive B cells (CD19 + CD27 − BTLA low ). Each dot represents an individual patient sample ( n = 16), and bars represent the mean ± SD. Statistical analyses were performed using a mixed-effects model followed by Dunnett’s post hoc test to compare the data before and 1, 3, 6, and 12 months after treatment. Statistically significant changes are marked with asterisks (* p < 0.05, ** p < 0.01, and *** p < 0.001).
    Anti Cd19 Apc Vio770, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti cd19 apc vio770/product/Miltenyi Biotec
    Average 95 stars, based on 1 article reviews
    anti cd19 apc vio770 - by Bioz Stars, 2026-02
    95/100 stars
    		  Buy from Supplier

    Image Search Results


    Belimumab treatment affects the B-cell subpopulations in patients with SLE. FACS analysis was performed on B cell subsets within the PBMCs isolated from patients with SLE before and 1, 3, 6, and 12 months after treatment with belimumab. ( A – C ) Frequencies of all cell subsets: ( A ) Total B cells (CD3 − CD19 + ), ( B ) HVEM high naive B cells (CD19 + CD27 − HVEM high ), HVEM high memory B cells (CD19 + CD27 + HVEM high ), ( C ) BTLA high naive B cells (CD19 + CD27 − BTLA high ), BTLA high memory B cells (CD19 + CD27 + BTLA high ), and BTLA low naive B cells (CD19 + CD27 − BTLA low ). Each dot represents an individual patient sample ( n = 16), and bars represent the mean ± SD. Statistical analyses were performed using a mixed-effects model followed by Dunnett’s post hoc test to compare the data before and 1, 3, 6, and 12 months after treatment. Statistically significant changes are marked with asterisks (* p < 0.05, ** p < 0.01, and *** p < 0.001).

    Journal: International Journal of Molecular Sciences

    Article Title: BTLA-Expressing Memory B Cells Are Associated with Belimumab-Induced Improvement in Systemic Lupus Erythematosus

    doi: 10.3390/ijms262311323

    Figure Lengend Snippet: Belimumab treatment affects the B-cell subpopulations in patients with SLE. FACS analysis was performed on B cell subsets within the PBMCs isolated from patients with SLE before and 1, 3, 6, and 12 months after treatment with belimumab. ( A – C ) Frequencies of all cell subsets: ( A ) Total B cells (CD3 − CD19 + ), ( B ) HVEM high naive B cells (CD19 + CD27 − HVEM high ), HVEM high memory B cells (CD19 + CD27 + HVEM high ), ( C ) BTLA high naive B cells (CD19 + CD27 − BTLA high ), BTLA high memory B cells (CD19 + CD27 + BTLA high ), and BTLA low naive B cells (CD19 + CD27 − BTLA low ). Each dot represents an individual patient sample ( n = 16), and bars represent the mean ± SD. Statistical analyses were performed using a mixed-effects model followed by Dunnett’s post hoc test to compare the data before and 1, 3, 6, and 12 months after treatment. Statistically significant changes are marked with asterisks (* p < 0.05, ** p < 0.01, and *** p < 0.001).

    Article Snippet: Anti-CD4-allophycocyanin (APC), anti-CD3-APC, anti-CD19-fluorescein isothiocyanate, and anti-CD19-phycoerythrin mAbs were purchased from Miltenyi Biotec.

    Techniques: Isolation